Cargando…

Noradrenaline and Parkinson's Disease

Parkinson's disease (PD) is characterized by the degeneration of dopamine (DA) neurons in the substantia nigra pars compacta, and motor symptoms including bradykinesia, rigidity, and tremor at rest. These symptoms are exhibited when striatal dopamine concentration has decreased by around 70%. I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Delaville, Claire, Deurwaerdère, Philippe De, Benazzouz, Abdelhamid
Formato:	Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2011
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103977/ https://www.ncbi.nlm.nih.gov/pubmed/21647359 http://dx.doi.org/10.3389/fnsys.2011.00031

Ejemplares similares

Lead-Induced Atypical Parkinsonism in Rats: Behavioral, Electrophysiological, and Neurochemical Evidence for a Role of Noradrenaline Depletion
por: Sabbar, Mariam, et al.
Publicado: (2018)

Manganese-Induced Atypical Parkinsonism Is Associated with Altered Basal Ganglia Activity and Changes in Tissue Levels of Monoamines in the Rat
por: Bouabid, Safa, et al.
Publicado: (2014)

Impairment of Serotonergic Transmission by the Antiparkinsonian Drug L-DOPA: Mechanisms and Clinical Implications
por: Miguelez, Cristina, et al.
Publicado: (2017)

Dopaminergic Control of the Globus Pallidus through Activation of D2 Receptors and Its Impact on the Electrical Activity of Subthalamic Nucleus and Substantia Nigra Reticulata Neurons
por: Mamad, Omar, et al.
Publicado: (2015)

Involvement of dopamine loss in extrastriatal basal ganglia nuclei in the pathophysiology of Parkinson’s disease
por: Benazzouz, Abdelhamid, et al.
Publicado: (2014)

Lorcaserin Alters Serotonin and Noradrenaline Tissue Content and Their Interaction With Dopamine in the Rat Brain
por: Di Giovanni, Giuseppe, et al.
Publicado: (2020)

Increased Noradrenaline as an Additional Cerebrospinal Fluid Biomarker in PSP-Like Parkinsonism
por: Cerroni, Rocco, et al.
Publicado: (2020)

Non-Motor Symptoms of Parkinson’s Disease and Their Impact on Quality of Life in a Cohort of Moroccan Patients
por: Tibar, Houyam, et al.
Publicado: (2018)

Noradrenaline blockade specifically enhances metacognitive performance
por: Hauser, Tobias U, et al.
Publicado: (2017)

Dopamine and Noradrenaline in the Brain; Overlapping or Dissociate Functions?
por: Ranjbar-Slamloo, Yadollah, et al.
Publicado: (2020)

The Locus Coeruleus Noradrenaline System in Delirium
por: Hansen, Niels, et al.
Publicado: (2021)

A Subset of Purposeless Oral Movements Triggered by Dopaminergic Agonists Is Modulated by 5-HT(2C) Receptors in Rats: Implication of the Subthalamic Nucleus
por: Lagière, Mélanie, et al.
Publicado: (2020)

Non-Human Primate: An Essential Building Brick in the Discovery of the Subthalamic Deep Brain Stimulation Therapy
por: Benazzouz, Abdelhamid, et al.
Publicado: (2016)

Role of Glycogenolysis in Memory and Learning: Regulation by Noradrenaline, Serotonin and ATP
por: Gibbs, Marie E.
Publicado: (2016)

Human complex exploration strategies are enriched by noradrenaline-modulated heuristics
por: Dubois, Magda, et al.
Publicado: (2021)

PET imaging of noradrenaline transporters in Parkinson’s disease: focus on scan time
por: Brumberg, Joachim, et al.
Publicado: (2018)

Noradrenalin and dopamine receptors both control cAMP-PKA signaling throughout the cerebral cortex
por: Nomura, Shinobu, et al.
Publicado: (2014)

Pupil Dilation Signals Surprise: Evidence for Noradrenaline’s Role in Decision Making
por: Preuschoff, Kerstin, et al.
Publicado: (2011)

Astrocytes, Noradrenaline, α1-Adrenoreceptors, and Neuromodulation: Evidence and Unanswered Questions
por: Wahis, Jérôme, et al.
Publicado: (2021)

Editorial: Non-Dopaminergic Systems in Parkinson’s Disease
por: Miguelez, Cristina, et al.
Publicado: (2020)

Noradrenaline and Movement Initiation Disorders in Parkinson’s Disease: A Pharmacological Functional MRI Study with Clonidine
por: Criaud, Marion, et al.
Publicado: (2022)

Interactions between noradrenaline and corticosteroids in the brain: from electrical activity to cognitive performance
por: Krugers, Harm J., et al.
Publicado: (2012)

Antagonistic modulation of NPY/AgRP and POMC neurons in the arcuate nucleus by noradrenalin
por: Paeger, Lars, et al.
Publicado: (2017)

Circadian Clock Protein Content and Daily Rhythm of Locomotor Activity Are Altered after Chronic Exposure to Lead in Rat
por: Sabbar, Mariam, et al.
Publicado: (2017)

Neurobiological and Pharmacological Perspectives of D3 Receptors in Parkinson’s Disease
por: Chagraoui, Abdeslam, et al.
Publicado: (2022)

Sex-Related Differential Whole-Brain Input Atlas of Locus Coeruleus Noradrenaline Neurons
por: Sun, Pei, et al.
Publicado: (2020)

Noradrenaline-induced release of newly-synthesized accumbal dopamine: differential role of alpha- and beta-adrenoceptors
por: Meyer, Francisca, et al.
Publicado: (2014)

The Noradrenergic System in Parkinson’s Disease
por: Paredes-Rodriguez, Elena, et al.
Publicado: (2020)

Effect of Noradrenaline on the Facial Stimulation-Evoked Mossy Fiber-Granule Cell Synaptic Transmission in Mouse Cerebellar Cortex
por: Li, Bing-Xue, et al.
Publicado: (2021)

Commentary: Noradrenaline and Dopamine Neurons in the Reward/Effort Trade-off: A Direct Electrophysiological Comparison in Behaving Monkeys
por: Ang, Yuen-Siang, et al.
Publicado: (2015)

Noradrenaline transporter PET reflects neurotoxin-induced noradrenaline level decrease in the rat hippocampus
por: Sakai, Takayuki, et al.
Publicado: (2023)

L-DOPA in Parkinson’s Disease: Looking at the “False” Neurotransmitters and Their Meaning
por: Chagraoui, Abdeslam, et al.
Publicado: (2019)

Switch of serotonergic descending inhibition into facilitation by a spinal chloride imbalance in neuropathic pain
por: Aby, Franck, et al.
Publicado: (2022)

Noradrenaline and the kidney: friends or foes?
por: Bellomo, Rinaldo, et al.
Publicado: (2001)

Monoaminergic control of spinal locomotor networks in SOD1(G93A) newborn mice
por: Milan, Léa, et al.
Publicado: (2014)

Rapid Eye Movement Sleep Deprivation Induces Neuronal Apoptosis by Noradrenaline Acting on Alpha1 Adrenoceptor and by Triggering Mitochondrial Intrinsic Pathway
por: Somarajan, Bindu I., et al.
Publicado: (2016)

Noradrenaline Acting on Alpha1 Adrenoceptor as well as by Chelating Iron Reduces Oxidative Burden on the Brain: Implications With Rapid Eye Movement Sleep
por: Singh, Abhishek, et al.
Publicado: (2019)

Neuroplasticity Regulation by Noradrenaline in Mammalian Brain
por: Marzo, Aude, et al.
Publicado: (2009)

Pharmacological evidence for the implication of noradrenaline in effort
por: Borderies, Nicolas, et al.
Publicado: (2020)

The role of noradrenaline in cognition and cognitive disorders
por: Holland, Negin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d5ifk5uditpi1uqaogq1bt07i1